Concepts (86)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Acceptance and Commitment Therapy | 2 | 2024 | 9 | 1.140 |
Why?
|
| Pain Management | 2 | 2025 | 146 | 1.030 |
Why?
|
| Chronic Pain | 2 | 2025 | 134 | 1.000 |
Why?
|
| Veterans | 7 | 2024 | 728 | 0.710 |
Why?
|
| Community Integration | 3 | 2018 | 7 | 0.340 |
Why?
|
| Social Support | 2 | 2018 | 355 | 0.240 |
Why?
|
| Antiretroviral Therapy, Highly Active | 4 | 2005 | 93 | 0.240 |
Why?
|
| Stress Disorders, Post-Traumatic | 2 | 2020 | 380 | 0.230 |
Why?
|
| Self-Management | 1 | 2025 | 55 | 0.230 |
Why?
|
| Pilot Projects | 2 | 2024 | 914 | 0.210 |
Why?
|
| United States Department of Veterans Affairs | 4 | 2024 | 519 | 0.210 |
Why?
|
| Tobacco Use Cessation | 1 | 2022 | 29 | 0.200 |
Why?
|
| Opioid-Related Disorders | 2 | 2021 | 456 | 0.200 |
Why?
|
| Feasibility Studies | 1 | 2024 | 525 | 0.200 |
Why?
|
| Transgender Persons | 1 | 2022 | 62 | 0.190 |
Why?
|
| Sexual and Gender Minorities | 1 | 2022 | 70 | 0.180 |
Why?
|
| Naltrexone | 2 | 2021 | 77 | 0.180 |
Why?
|
| Buprenorphine | 2 | 2021 | 181 | 0.170 |
Why?
|
| Mental Health | 2 | 2023 | 335 | 0.170 |
Why?
|
| Narcotic Antagonists | 2 | 2021 | 121 | 0.170 |
Why?
|
| Adult | 10 | 2024 | 15669 | 0.160 |
Why?
|
| Robotics | 1 | 2019 | 69 | 0.150 |
Why?
|
| Pandemics | 1 | 2023 | 615 | 0.150 |
Why?
|
| Rehabilitation, Vocational | 1 | 2018 | 30 | 0.150 |
Why?
|
| Employment, Supported | 1 | 2018 | 20 | 0.150 |
Why?
|
| Self-Help Groups | 1 | 2018 | 37 | 0.150 |
Why?
|
| Education | 1 | 2018 | 68 | 0.140 |
Why?
|
| AIDS-Related Opportunistic Infections | 3 | 2005 | 68 | 0.140 |
Why?
|
| Middle Aged | 8 | 2024 | 16317 | 0.130 |
Why?
|
| Adaptation, Psychological | 1 | 2018 | 259 | 0.130 |
Why?
|
| Humans | 16 | 2025 | 59360 | 0.120 |
Why?
|
| Male | 10 | 2024 | 27739 | 0.120 |
Why?
|
| Emergency Service, Hospital | 1 | 2023 | 1021 | 0.120 |
Why?
|
| Aged | 6 | 2024 | 13416 | 0.120 |
Why?
|
| Ambulatory Care | 3 | 2005 | 300 | 0.120 |
Why?
|
| United States | 9 | 2024 | 7390 | 0.110 |
Why?
|
| Female | 9 | 2024 | 30705 | 0.110 |
Why?
|
| HIV Infections | 3 | 2005 | 913 | 0.080 |
Why?
|
| Injections, Intramuscular | 2 | 2021 | 67 | 0.080 |
Why?
|
| Veterans Health | 2 | 2024 | 158 | 0.080 |
Why?
|
| Hospitalization | 2 | 2005 | 1290 | 0.070 |
Why?
|
| Young Adult | 3 | 2022 | 4267 | 0.060 |
Why?
|
| Mycobacterium avium-intracellulare Infection | 1 | 2005 | 8 | 0.060 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 2005 | 18 | 0.060 |
Why?
|
| Health Resources | 1 | 2005 | 87 | 0.060 |
Why?
|
| Hospitals, Military | 1 | 2023 | 1 | 0.050 |
Why?
|
| Exercise Therapy | 1 | 2024 | 99 | 0.050 |
Why?
|
| Multivariate Analysis | 4 | 2005 | 902 | 0.050 |
Why?
|
| Retrospective Studies | 3 | 2023 | 6071 | 0.050 |
Why?
|
| Buprenorphine, Naloxone Drug Combination | 1 | 2021 | 25 | 0.050 |
Why?
|
| Caregivers | 1 | 2024 | 231 | 0.050 |
Why?
|
| Confidence Intervals | 3 | 2005 | 241 | 0.040 |
Why?
|
| Delayed-Action Preparations | 1 | 2021 | 111 | 0.040 |
Why?
|
| Mental Health Services | 1 | 2023 | 268 | 0.040 |
Why?
|
| Cohort Studies | 4 | 2005 | 2374 | 0.040 |
Why?
|
| Odds Ratio | 3 | 2005 | 745 | 0.040 |
Why?
|
| Mobile Applications | 1 | 2019 | 129 | 0.040 |
Why?
|
| Peer Group | 1 | 2018 | 95 | 0.040 |
Why?
|
| Workplace | 1 | 2018 | 169 | 0.030 |
Why?
|
| Methadone | 1 | 2017 | 127 | 0.030 |
Why?
|
| Mental Disorders | 1 | 2023 | 717 | 0.030 |
Why?
|
| Family | 1 | 2018 | 229 | 0.030 |
Why?
|
| Cross-Sectional Studies | 2 | 2017 | 2373 | 0.030 |
Why?
|
| Counseling | 1 | 2018 | 349 | 0.030 |
Why?
|
| Aged, 80 and over | 4 | 2005 | 5128 | 0.030 |
Why?
|
| Comorbidity | 1 | 2017 | 1078 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2021 | 3067 | 0.030 |
Why?
|
| Patient Admission | 2 | 2005 | 184 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2017 | 483 | 0.030 |
Why?
|
| Length of Stay | 2 | 2005 | 775 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2017 | 5284 | 0.020 |
Why?
|
| Poisson Distribution | 1 | 2005 | 52 | 0.020 |
Why?
|
| Medical Records | 1 | 2005 | 133 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2005 | 244 | 0.010 |
Why?
|
| Sampling Studies | 1 | 2005 | 65 | 0.010 |
Why?
|
| Health Care Surveys | 1 | 2005 | 271 | 0.010 |
Why?
|
| Primary Prevention | 1 | 2005 | 134 | 0.010 |
Why?
|
| Health Services Needs and Demand | 1 | 2005 | 203 | 0.010 |
Why?
|
| Poverty | 1 | 2005 | 281 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 2005 | 197 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2005 | 741 | 0.010 |
Why?
|
| Logistic Models | 1 | 2005 | 1232 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2005 | 521 | 0.010 |
Why?
|
| Primary Health Care | 1 | 2005 | 643 | 0.010 |
Why?
|
| Risk Factors | 1 | 2005 | 4984 | 0.010 |
Why?
|
| Adolescent | 1 | 2005 | 5824 | 0.010 |
Why?
|